Dowling & Yahnke’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.37M Buy
7,320
+328
+5% +$70.4K 0.06% 205
2022
Q2
$1.4M Buy
6,992
+156
+2% +$36.6K 0.07% 201
2022
Q1
$2.06M Sell
6,836
-481
-7% -$141K 0.09% 175
2021
Q4
$2.63M Buy
7,317
+816
+13% +$281K 0.13% 155
2021
Q3
$2.15M Buy
6,501
+396
+6% +$133K 0.12% 164
2021
Q2
$1.87M Buy
6,105
+621
+11% +$174K 0.11% 170
2021
Q1
$1.35M Buy
5,484
+573
+12% +$144K 0.09% 180
2020
Q4
$1.34M Buy
4,911
+354
+8% +$87.9K 0.1% 175
2020
Q3
$1.08M Buy
4,557
+285
+7% +$64K 0.09% 176
2020
Q2
$811K Buy
4,272
+891
+26% +$160K 0.07% 200
2020
Q1
$558K Sell
3,381
-807
-19% -$148K 0.05% 206
2019
Q4
$825K Buy
4,188
+402
+11% +$75.3K 0.06% 203
2019
Q3
$681K Buy
3,786
+207
+6% +$35.8K 0.06% 214
2019
Q2
$626K Sell
3,579
-366
-9% -$62.7K 0.05% 219
2019
Q1
$750K Buy
3,945
+2,655
+206% +$472K 0.07% 187
2018
Q4
$228K Buy
+1,290
New +$219K 0.02% 238

Other funds holding ISRG

Dowling & Yahnke's ISRG Position: Q3 2022 in Review

Dowling & Yahnke increased its Intuitive Surgical (ISRG) stake by 4.7% in Q3 2022, buying an estimated $70.4K and bringing the position to 7,320 shares worth $1.37M. The position accounts for 0.06% of the portfolio, ranked #205.

Dowling & Yahnke first reported a position in ISRG in Q4 2018 and has held it in 16 quarters since. The position peaked at $2.63M in Q4 2021. 1,308 funds tracked by Wall St. Rank hold ISRG as of Q3 2022.

  • Dowling & Yahnke held 7,320 shares of Intuitive Surgical worth $1.37M as of Q3 2022.
  • Dowling & Yahnke bought 328 Intuitive Surgical shares in Q3 2022, an estimated $70.4K.
  • Intuitive Surgical made up 0.06% of Dowling & Yahnke's portfolio in Q3 2022, its #205 holding.
  • Dowling & Yahnke first reported a position in Intuitive Surgical in Q4 2018 and has held it in 16 quarters since.
  • Dowling & Yahnke's Intuitive Surgical position peaked at $2.63M in Q4 2021.
  • 1,308 funds tracked by Wall St. Rank held Intuitive Surgical as of Q3 2022.

Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.